[{"Assets_0_Q3_USD":70161801.0,"CommonStockSharesOutstanding_0_Q3_shares":40588004.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":376755.0,"NetIncomeLoss_1_Q3_USD":11537478.0,"NetIncomeLoss_3_Q3_USD":-1878046.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":40961620.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":31687434.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":40527722.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":31687434.0,"StockholdersEquity_0_Q3_USD":66517116.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":18821953.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":20155286.0,"Ticker":"AADI","CIK":"1422142","name":"AERPIO PHARMACEUTICALS, INC.","OfficialName":"Aadi Bioscience Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"339479977.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181107"}]